Search results
Dr. David E. Martin is the Founder and Chairman of M·CAM Inc., the international leader in innovation finance, trade, and intangible asset finance. He is the developer of the first innovation-based quantitative index of public equities and is the Managing Partner of the Purple Bridge Funds.
- The Patent of SARS-CoV by The CDC Was Not For Profit
- The Patent Was Not Illegal, and The Virus Is Not Man-Made
- Our Ruling: False
- Our Fact-Check Sources
It's true that the CDC filed a patent application on SARS-CoV in 2004; it was granted in 2007. Martin, in a follow-up email to USA TODAY, said the intentions behind the patent were to create a monopoly, and that the CDC’s statements regarding the patent are "falsified by their own actions." But contrary to Martin's claims of complete proprietary co...
But was the patent illegal? It's true that the Patent Act prohibits patents on "natural phenomena," and the Supreme Court ruled in 2013that a naturally occurring DNA segment is a product of nature and not eligible for patent protection. However, the high court found that complimentary DNA — known as cDNA — "is not a 'product of nature' and is paten...
Based on our research, the claim that the pandemic was "planned" or created by the CDC, NIH, EcoHealth Alliance, or the Wuhan Virology Institute is FALSE. "Plandemic II: Indoctornation" is based on a number of cherry-picked facts, such as the existence of a patent on the genome of SARS-CoV, and the transfer of funds from the NIH to EcoHealth Allian...
National Institutes of Health, Research Online Portfolio Reporting Tools, Project Information: Understanding the Risk of Bat Coronavirus Emergence (2014-2019)Centers for Disease Control and Prevention, May 6, 2003, CDC Telebriefing Transcript: CDC Update on Severe Acute Respiratory Syndrome (SARS)Supreme Court of the United States, June 13, 2013, Association for Molecular Pathology Et Al. v Myriad Genetics, Inc., Et Al.David E. Martin, PhD. Dr. David Martin founded M·CAM ® in 1998 and has served as its CEO and Chairman since that time. M·CAM ® has been an international intangible asset underwriter and analyst firm spanning work in innovation finance, trade, and intangible asset finance.
People also ask
Who is David Martin?
Who is David Earl Martin?
Who is Dr Martin?
Who is John Martin?
Dr. David E. Martin is the Founder and Chairman of M·CAM Inc., the international leader in innovation finance, trade, and intangible asset finance. He is the developer of the first innovation-based quantitative index of public equities and is the Managing Partner of the Purple Bridge Funds.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.
M-CAM, USA. David E. Martin, PhD, is the founding CEO of M·CAM, Inc., the international leader in intellectual property-based financial risk management.
